期刊
CANCER AND METASTASIS REVIEWS
卷 28, 期 3-4, 页码 269-280出版社
SPRINGER
DOI: 10.1007/s10555-009-9190-y
关键词
Genome-wide analysis; GWAS; Human genome project; Database; Bladder cancer; Genetic variants; Clinical outcome; Risk prediction model
类别
资金
- NIH [U01 CA 127615, R01 CA 74880]
- National Cancer Institute
- NATIONAL CANCER INSTITUTE [U01CA127615, R01CA074880] Funding Source: NIH RePORTER
The advent of the genome era after the completion of the Human Genome Project has resulted in intensive efforts to identify all genetic variants that modify human health and disease, including cancer. The development of genome-wide association study (GWAS) approach has facilitated this goal by unbiased examination of the entire human genome for disease association. Here, we review some of the GWAS data, particularly for bladder cancer, and assess their significance in risk prediction and prognosis. A mechanistic understanding of the risk association through functional studies and phenotypic assays is also discussed. The ultimate goal is the development of a comprehensive risk prediction model which integrates genetic, environment, and person risk factors to benefit disease diagnosis, prevention, and treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据